Neimeth International Pharmaceuticals on Tuesday published its Audited Financial Statement for the year ended 30, September, 2020.
The firm declared a turnover of N2.839 billion, up by 19.73% from the turnover of N2.371 billion reported the previous year.
Profit before tax (PBT) was N297.388 million, down by 2.32% from the PBT of N304.439 million reported the previous year.
Neimeth declared a profit after tax of N212.476 million, down by 3.48% from N220.147 million achieved the previous year. Earnings per share (EPS) dropped to 11 kobo from EPS of 12 kobo reported in 2019.
With reference to the share price of N2.3, the P.E ratio of Neimeth stands at 20.56x with earnings yield of 4.86%.